Previous research in humans has shown that serum L-FABP level is a prognostic factor and predictor of survival in patients with chronic liver disease, including chronic hepatitis, liver cirrhosis, and HCC [26]. This evidence concerns the gene FABP1 and hepatocellular carcinoma.